Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

BAYN:GR

128.000 EUR 1.562 1.21%

As of 10:54:05 ET on 01/30/2015.

Snapshot for Bayer AG (BAYN)

Open: 129.380 Day's Range: 127.000 - 129.800 Volume: 1,433,072
Previous Close: 129.562 52wk Range: 89.490 - 130.900 1-Yr Rtn: +33.59%

Stock Chart for BAYN

No chart data available.
  • BAYN:GR 127.850
  • 1D
  • 1M
  • 1Y
129.562
Interactive BAYN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BAYN

Current P/E Ratio (ttm) 28.8575
Estimated P/E(12/2014) 21.1036
Relative P/E vs. DAX 1.6395
Earnings Per Share (EUR) (ttm) 4.4200
Est. EPS (EUR) (12/2014) 6.0440
Est. PEG Ratio 2.1937
Market Cap (M EUR) 105,477.19
Shares Outstanding (M) 826.95
30 Day Average Volume 2,663,327
Price/Book (mrq) 5.2312
Price/Sale (ttm) 2.5701
Dividend Indicated Gross Yield 1.65%
Cash Dividend (EUR) 2.1000
Dividend Ex-Date 04/30/2014
5 Year Dividend Growth 8.45%
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BAYN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BAYN

Bayer AG produces and markets healthcare and agricultural products, and polymers. The Company manufactures products that include aspirin, antibiotics, anti-infectives, and cardiovascular, oncology, and central nervous system drugs, over-the-counter medications, diagnostics, animal health products, crop protection products, plastics, and polyurethanes.

Marijn E DekkersChairman-Mgmt Board/CEOWerner BaumannChief Strategy & Portfolio Officer
Michael KoenigMember-Mgmt Bd/Dir:LaborKemal MalikMember-Mgmt Bd:Innovation
More Company Profile & Key Executives for BAYN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil